# FDA recall D-0331-2022

> **Perrigo Company PLC** · Class II · drug recall initiated 2021-07-27.

## Product

basic+care, allergy Fexofenadine Hydrochloride Tablets, 180 mg/Antihistamine,  24 HR, 150 count bottle, Made in the Czech Republic, Distributed by: Perrigo Allergan, MI 49010, NDC 0113-7571-47 UPC 3 70030 11470 2

## Reason for recall

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0331-2022
- **Recalling firm:** Perrigo Company PLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-07-27
- **Report date:** 2022-01-12
- **Termination date:** 2022-11-08

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Allegan, MI, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0331-2022

## Citation

> AI Analytics. FDA recall D-0331-2022. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0331-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*